Monday, November 9, 2026

USD/EUR Went Down By Over 2% In The Last 21 Sessions

USD/EUR Went Down By Over 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2% for the last 21 sessions. At 09:09 EST on Thursday, 14 March, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.18% up from its 52-week low and 4.378% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a negative 0.11%, and a positive 0.27%, respectively.

USD/EUR's highest amplitude of average volatility was 0.17% (last week), 0.19% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd price analysis: the bullish outlook remains intact above the 1.0900 mark. According to FXStreet on Tuesday, 12 March, "The EUR/USD pair gains momentum below the mid-1.0900s during the early European trading hours on Tuesday. ", " According to the four-hour chart, EUR/USD keeps the bullish vibe unchanged as the major pair is above the key 50- and 100-period Exponential Moving Averages (EMA) with an upward slope. "
  • According to FXStreet on Wednesday, 13 March, "At the time of writing, the EUR/USD pair is trading higher at 1.0927, gaining 0.01% on the day."
  • Eur/usd analysis: gains stall ahead of key US data - 12 March 2024. According to DailyForex on Tuesday, 12 March, "We tend to view the major moving averages as an indicator of where momentum is, and the EUR/USD price is sitting above the 50-, 100- and 200-day moving averages. ", "Only when the pair starts to fall below these levels will we put the EUR/USD rate on alert for a broader decline."
  • Eur/usd inches higher to near 1.0930, focus on US inflation data. According to FXStreet on Tuesday, 12 March, "A robust CPI report would likely dampen prospects of an imminent rate cut by the Federal Reserve (Fed), potentially strengthening the US Dollar (USD) and presenting challenges for the EUR/USD pair.", "The optimistic outlook surrounding the ECB could offer bolstering for the Euro, thereby supporting the EUR/USD pair. "
  • Eur/usd middled on Tuesday after mixed US CPI inflation print pins pair. According to FXStreet on Tuesday, 12 March, "The EUR/USD spent most of Tuesday cycling familiar territory, with the pair churning chart paper just north of 1.0900. ", "The EUR/USD set a fresh weekly high at 1.0980 on Monday, and the pair continues to see near-term technical support from a shortrun rising trendline."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com